Paid Clinical Trials and Focus Groups by Location |
|
|
|
Condition: ST Segment Elevation Acute Coronary Syndrome
Interventions: Drug: Bivalirudin; Drug: Heparin
Sponsor: The Medicines Company
Recruiting - verified March 2010
Condition: Wet Age-Related Macular Degeneration
Intervention: Biological: MP0112
Sponsor: Molecular Partners AG
Recruiting - verified March 2010
Condition: Idiopathic Menorrhagia
Interventions: Drug: Levonorgestrel (Mirena, BAY86-5028); Drug: Hormonal treatment; Drug: Antifibrinolytic treatment
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Postoperative Pain
Interventions: Drug: Morphine 6-glucuronide; Drug: Morphine
Sponsors: Paion UK Ltd.; Chiltern International Ltd.; HFL Ltd.
Completed - verified March 2010
Condition: Congestive Heart Failure
Intervention:
Sponsor: University Hospital Hradec Kralove
Recruiting - verified February 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium and Formoterol; Drug: Placebo; Drug: Formoterol; Drug: Aclidinium; Drug: Aclidinium and Formoterol
Sponsors: Almirall, S.A.; Forest Laboratories
Recruiting - verified March 2010
Condition: Hypertension
Intervention:
Sponsor: Abbott
Completed - verified March 2010
Conditions: Active Rheumatoid Arthritis; Osteoporoses
Intervention:
Sponsors: Abbott; Centre of Biostatistics and Analyses, Faculty of Medicine, Masaryk University Brno, Czech Republic
Recruiting - verified February 2010
Condition: Ovarian Cancer
Interventions: Drug: olaparib; Drug: paclitaxel; Drug: carboplatin
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Hormone Withdrawal Associated Symptoms
Interventions: Drug: EE20/DRSP (YAZ, BAY86-5300); Drug: Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Morbid Obesity
Intervention: Procedure: Gastric Plication
Sponsor: Ethicon Endo-Surgery
Active, not recruiting - verified February 2010
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Rebif (Interferon beta-1a)
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: LY2189265
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Condition: Chronic Plaque Psoriasis
Interventions: Drug: BT061; Drug: placebo treatment
Sponsor: Biotest
Recruiting - verified March 2010
Condition: Intra-abdominal Infection
Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039); Drug: Ertapenem, Amoxicillin/clavulanate
Sponsor: Bayer
Not yet recruiting - verified March 2010